Fig 1.
Trial profile. (*) Reasons for not meeting inclusion criteria: poor liver functions (n = 14; including bilirubin > 30 μmol/L [n = 11], ALP > 600 IU/L [n = 1], ALT, 5 × upper limit of normal [n = 1], albumin < 20 g/dL [n = 1]), platelet count < 100 × 109/L (n = 5), poor performance status (n = 3), abnormal electrocardiogram (n = 1), active wound infection (n = 1), and liver biopsy unable to confirm hepatocellular carcinoma (n = 1).